CARDIONOMIC
Cardionomic treats reduced cardiac output – ADHF’s root cause – by neuromodulating the terminal branches of the cardiac plexus to benignly increase contractility. Cardionomic’s acute, non-systemic therapy will improve cardiac output, renal blood flow, urine production, and pharmacological tolerance. Concurrently the therapy also achieves the associated decreases in plasma norepinephrine (NE) and B-type natriuretic peptide (BNP), which are objective biomarkers of chronic heart failure.
CARDIONOMIC
Social Links:
Industry:
Health Care Medical Device Therapeutics
Founded:
2011-01-01
Address:
Forest Lake, Minnesota, United States
Country:
United States
Website Url:
http://www.cardionomicinc.com
Total Employee:
1+
Status:
Active
Contact:
(651)964-0170
Email Addresses:
[email protected]
Total Funding:
49.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Employees Featured
Founder
Investors List
Greatbatch
Greatbatch investment in Venture Round - Cardionomic
Cleveland Clinic
Cleveland Clinic investment in Venture Round - Cardionomic
Ascension Ventures
Ascension Ventures investment in Venture Round - Cardionomic
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Cardionomic
Greatbatch
Greatbatch investment in Series A - Cardionomic
New Enterprise Associates
New Enterprise Associates investment in Series A - Cardionomic
Cleveland Clinic
Cleveland Clinic investment in Series A - Cardionomic
Official Site Inspections
http://www.cardionomicinc.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 13.248.213.45
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Cardionomic"
Cardionomic - Crunchbase Company Profile & Funding
Organization. Cardionomic . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Cardionomic is a medical device developer that …See details»
Cardionomic - LinkedIn
Cardionomic | 815 followers on LinkedIn. Cardionomic is developing a transformative, neuromodulation treatment to address a large unmet need for patients suffering from acute decompensated heart ...See details»
Cardionomic, Inc. Company Profile | New Brighton, MN
Find company research, competitor information, contact details & financial data for Cardionomic, Inc. of New Brighton, MN. Get the latest business insights from Dun & Bradstreet.See details»
Cardionomic Company Profile | Management and Employees List
Cardionomic, Inc. is a privately held U.S. company that designs, produces, and markets devices to address heart failure. Popular Searches. cardionomic Inc. Cardionomic. Nomic Inc. …See details»
Cardionomic - Overview, News & Similar companies - ZoomInfo
Explore Complete Organization Structure. Is Cardionomic your ideal customer? Let us give you the heads up on whether it's a good time to reach out. ... Nov. 2, 2021 /PRNewswire/ -- …See details»
Cardionomic 2025 Company Profile: Valuation, Funding …
Cardionomic General Information Description. Developer of a cardiac therapy device designed to treat acute decompensated heart failure. The company's …See details»
Cardionomic Announces Enrollment Completion in the STIM …
Jan 3, 2024 Cardionomic, Inc. is a privately held U.S. company that designs and produces devices to address heart failure. For more information on the company and its products, …See details»
Cardionomic Company Overview, Contact Details & Competitors
Oct 4, 2021 Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial U.S. enrollment in their global Cardiac Pulmonary Nerve Stimulation (CPNS) Pilot Study …See details»
Cardionomic - Craft
Cardionomic is a company that provides cardiac treatments intended to be used for treating acute decompensated heart failure. Its cardiac treatments address the condition's root cause of …See details»
Cardionomic, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cardionomic, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 3 news.See details»
Steve Goedeke - President & Chief Executive Officer at
Steve Goedeke contact details: Email address: s***@cardionomicinc.com Phone number: (651) ***-**** Who is Steve Goedeke? Steve Goedeke is the President & Chief Executive Officer at Cardionomic based in New Brighton, Minnesota. Previously, Steve was the President & Chief Executive Officer at Denali Medical Center and also held positions at ...See details»
First U.S. Patient Enrolled in Cardionomic’s CPNS Pilot Study
MINNEAPOLIS, Nov. 2, 2021 /PRNewswire/ -- Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial U.S. enrollment in their global Cardiac Pulmonary …See details»
First U.S. Patient Enrolled in Cardionomic's CPNS Pilot Study
Nov 2, 2021 Cardionomic, Inc. is a privately held U.S. company that designs and produces devices to address heart failure. For more information on the company and its products, …See details»
Cardionomic Raises Nearly $16M to Test Heart Failure …
Feb 24, 2020 New Brighton-based Cardionomic Inc. has raised $15.8 million to further clinical research of its neuromodulation device for heart failure. The company will primarily use the money to advance human ...See details»
Cardionomic Announces First Patients Enrolled in CPNS Pilot Study
Apr 15, 2021 Cardionomic, Inc. is a privately held U.S. company that designs, produces and markets devices to address heart failure. For more information on the company and its …See details»
Cardionomic’s CPNS System Pilot Studies Complete Enrollment
January 15, 2024—Cardionomic, Inc. announced the completion of enrollment in the STIM-ADHF and STOP-ADHF pilot studies. Both studies were designed to evaluate the safety and performance of the company’s cardiac pulmonary nerve stimulation (CPNS) system in patients with acute decompensated heart failure (ADHF). Data from the two studies will ...See details»
Working at Cardionomic, Inc: 2 Reviews - Indeed
Reviews from Cardionomic, Inc employees about Cardionomic, Inc culture, salaries, benefits, work-life balance, management, job security, and more.See details»
Cardionomic Announces Enrollment Completion in the STIM …
MINNEAPOLIS, Jan. 3, 2024 /PRNewswire/ -- Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of enrollment in both their STIM-ADHF and …See details»
Cardionomic Announces First Patient Enrolled in STIM-ADHF Study
May 19, 2022 — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial enrollment in their STIM-ADHF Study. The study will evaluate therapy …See details»
Cardionomic completes enrolment for cardiac neurostimulation …
Jan 5, 2024 US-based Cardionomic has completed the patient enrolment in its two pilot studies, STIM-ADHF and STOP-ADHF, evaluating the cardiac pulmonary nerve stimulation (CPNS) …See details»